DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (Amex: AXK) presented results from three studies related to its development of the BACcel™ rapid pathogen diagnostic platform at the 108th General Meeting of the American Society of Microbiology in Boston (www.asm.org). The meeting is one of the world’s largest international meetings for microbiologists.
